7 - Breast Flashcards
What is the epidemiology of breast cancer?
- Most common malignancy in women (1 in 8)
- Second most common cancer death after lung
- In top 20 for men
What are the risk factors for breast cancer?
THINK ABOUT OESTROGEN EXPOSURE
- Female gender
- Age
- Family history
- Personal history of breast cancer
- Genetic predispositions (e.g. BRCA 1, BRCA 2)
- Early menarche and late menopause
- Nulliparity
- Increased age of first pregnancy
- Multiparity (risk increased in period after birth, then protective later in life)
- Combined oral contraceptive
- Hormone replacement therapy
- White ethnicity
- Exposure to radiation
- Obesity
What type of HRT increases the risk of breast cancer?
Combined!!!!!
COCP also raises risk but risk back to normal after 10 years of stopping
What are the BRCA mutations and what do they increase the risk of?
- BRCA 1: mutation on chromosome 17 that predisposes patients to breast cancer, risk of 65-80% (compared to a baseline of around 12%) whilst the risk of ovarian cancer is 40-45% (compared to a baseline of around 1.3%).
- BRCA 2: mutation on chromosome 13 that predisposes patients to breast cancer, risk of breast cancer is approximately 45-70% whilst the risk of ovarian cancer is 11-25%.
Also known to increase the risk of peritoneal, endometrial, fallopian, pancreatic and prostate cancer.
What type of genes are BRCA1 and 2 and what are some other genes that predispose to breast cancer?
Tumour suppressor genes
TP53 and PTEN genes
What are the different types of breast cancer and where in the breast do they arise from?
- Ductal carcinoma in situ
- Invasive ductal carcinoma (MOST COMMON)
- Lobular carcinoma in situ
- Invasive lobular carcinoma
- Inflammatory breast cancer
- Paget’s disease
- Medullary
- Mucinous
- Tubular
What is special type vs non-special type breast cancer?
- Non-special type is invasive ductal carcinoma
- Special type is any lobular carcinomas, any ductal carcinoma in situ and others
What is Paget’s disease of the nipple and inflammatory breast cancer?
Inflammatory Breast Cancer
- 1-3% of breast cancers
- Cancer cells block lymphatic drainage so inflammed swollen breast
- Presents similarly to a breast abscess or mastitis
- Swollen, warm, tender breast with pitting skin (peau d’orange)
- Does not respond to antibiotics
- Worse prognosis than other breast cancers
Paget’s Disease of the Nipple
- Looks like eczema of the nipple/areolar
- Erythematous, scaly rash
- Indicates breast cancer involving the nipple
- May represent DCIS or invasive breast cancer
- Requires biopsy, staging and treatment
How do the following breast cancers present and act:
- DCIS
- NST
- LCIS
- ILC
Ductal Carcinoma In Situ (DCIS)
- Pre-cancerous or cancerous epithelial cells of the breast ducts
- Localised to single area but potential to become invasive
- Found on mammogram screening
- Good prognosis if full excised and adjuvant treatment is used
Invasive Ductal Carcinoma – NST (MOST COMMON)
- Originate in cells from the breast ducts
- 80% of invasive breast cancers fall into this category
- Can be seen on mammograms
Lobular Carcinoma In Situ (LCIS)
- Pre-cancerous condition occurring typically in pre-menopausal women
- Usually asymptomatic and undetectable on a mammogram
- Usually diagnosed incidentally on a breast biopsy
- Often managed with close monitoring (e.g 6 month exam and yearly mammograms)
Invasive Lobular Carcinomas (ILC)
- Around 10% of invasive breast cancers
- Not always visible on mammograms
What are the molecular subtypes of invasive breast cancer?
Depends on expression of oestrogen receptors, progesterone receptors, HER2 receptors and Ki67
- Luminal A
- Luminal B
- Basal
- HER2
Who in England is invited for breast cancer screening?
Women and trans-men/women aged 47-73 every 3 years (50-70 in the past)
May be invited younger if family history
What does breast screening involve and what are the different results?
Mammogram in caudal-cranial and mediolateral oblique views
- Satisfactory: no radiological evidence of breast cancer
- Abnormal: abnormality detected, further investigations needed. 25% of these will have cancer
- Unclear: results or imaging unclear or inadequate. Further investigations required
What are the pros and cons of breast cancer screening?
Pros
- Early detection of cancers
- Approximately 20% reduction in relative risk of death from breast cancer
- Can provide peace-of-mind for some patients
Cons
- Painful and undignified
- Not 100% sensitive (i.e. false negatives)
- Over treatment
- False positive results can be emotionally distressing for patients
- Exposure to radiation, with a very small risk of causing breast cancer
What patients are classed as being at ‘high-risk’ of breast cancer and need to be offered earlier screening?
- A first-degree relative with breast cancer under 40 years
- A first-degree male relative with breast cancer
- A first-degree relative with bilateral breast cancer, first diagnosed under 50 years
- Two first-degree relatives with breast cancer
What can people at high risk of breast cancer be offered?
- Genetic testing with pre-test counselling
- Annual mammogram potentially starting from aged 30
- Chemoprevention: Tamoxifen if premenopausal, Anastrozole if postmenopausal (except with severe osteoporosis)
- Risk-reducing bilateral mastectomy or bilateral oophorectomy
How may breast cancer present?
- Asymptomatic: picked up on screening
- Breast pain
- Axilla or breast lump
- Changes to skin on breast
- Changes to nipples: inversion, discharge
- Lymphadenopathy
- Metastatic complications: bone pain, headaches, seizures, SOB, jaundice etc
What is the referral criteria for a 2 week wait for breast cancer?
- >30 with unexplained breast lump with or without pain or
-
>50 with any of the following symptoms in one nipple only:
- Discharge
- Retraction
- Other changes of concern
- With skin changes that suggest breast cancer
- >30 with an unexplained lump in the axilla
What is the criteria for a non-urgent referral for breast changes?
Under 30 with unexplained breast lump with or without pain
What does in situ mean for a cancer?
Basement membrane is not breached
What investigations are done for a 2 week wait for breast cancer?
One Stop Clinic for triple assessment
- History and Examination
- Imaging: US if <40, mammogram if >40
- Histology: fine needle aspiration or core biopsy
What signs can a mammogram and US pick up that are suggestive of breast cancer?
- Mammogram: calcifications
- US: can tell cystic from solid lumps
If a triple assessment confirms breast cancer, what further investigations need to be done for the patient?
All with the aim to stage and look for metastases
Bloods
- FBC
- U+Es
- LFT
- Bone profile
Imaging
- CXR
- MRI breast: helps to guide treatment and plan surgery
- CT chest, abdo, pelvis
- CT brain: In symptomatic patients with suspected neurological spread.
- Contrast-enhanced liver USS
- Bone scan
Receptor Testing
- ER
- PR
- HER2 (human epidermal growth receptor)
Axilla Lymph Nodes
- FNA OR
- Sentinel node biopsy whilst having surgery
Genetic Testing
- If <50 and triple negative consider looking for BRCA½
What is gene expression profiling?
Assessing which genes are present within the breast cancer on a histology sample
Helps predict the probability that the breast cancer will reoccur as a distal metastasis (away from the original cancer site) within 10 years
Recommend this for women with early breast cancers that are ER positive but HER2 and lymph node negative. It helps guide whether to give additional chemotherapy